Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 8 studies | 26% ± 6% | |
precursor B cell | 6 studies | 40% ± 18% | |
pro-B cell | 5 studies | 39% ± 11% | |
plasma cell | 4 studies | 32% ± 12% | |
epithelial cell | 4 studies | 27% ± 13% | |
endothelial cell | 3 studies | 31% ± 4% | |
abnormal cell | 3 studies | 20% ± 1% | |
basal cell | 3 studies | 20% ± 1% |
Insufficient scRNA-seq data for expression of TCF3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2783.75 | 1445 / 1445 | 100% | 67.68 | 183 / 183 |
uterus | 100% | 4468.60 | 170 / 170 | 100% | 69.69 | 458 / 459 |
stomach | 100% | 2538.00 | 359 / 359 | 100% | 67.67 | 285 / 286 |
skin | 100% | 4615.36 | 1809 / 1809 | 100% | 51.99 | 470 / 472 |
ovary | 100% | 4414.18 | 180 / 180 | 100% | 51.52 | 428 / 430 |
intestine | 100% | 4503.73 | 966 / 966 | 99% | 71.69 | 524 / 527 |
bladder | 100% | 3556.33 | 21 / 21 | 99% | 64.00 | 501 / 504 |
breast | 100% | 3659.06 | 459 / 459 | 99% | 53.99 | 1110 / 1118 |
prostate | 100% | 3733.76 | 245 / 245 | 99% | 36.58 | 498 / 502 |
lung | 100% | 3380.79 | 577 / 578 | 99% | 55.53 | 1145 / 1155 |
thymus | 100% | 4427.67 | 653 / 653 | 99% | 46.49 | 598 / 605 |
brain | 99% | 1622.29 | 2623 / 2642 | 99% | 62.14 | 699 / 705 |
pancreas | 100% | 1952.80 | 327 / 328 | 98% | 46.43 | 175 / 178 |
kidney | 100% | 2916.19 | 89 / 89 | 96% | 26.30 | 863 / 901 |
adrenal gland | 100% | 2048.98 | 258 / 258 | 83% | 18.30 | 192 / 230 |
liver | 97% | 1151.50 | 220 / 226 | 71% | 18.81 | 288 / 406 |
adipose | 100% | 3037.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 150.08 | 29 / 29 |
spleen | 100% | 7585.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 65.83 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.28 | 1 / 1 |
blood vessel | 100% | 3128.35 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 5438.37 | 917 / 929 | 0% | 0 | 0 / 0 |
muscle | 99% | 1474.16 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1570.97 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 23.31 | 78 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002326 | Biological process | B cell lineage commitment |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0033152 | Biological process | immunoglobulin V(D)J recombination |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0007399 | Biological process | nervous system development |
GO_0030183 | Biological process | B cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0043425 | Molecular function | bHLH transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0070644 | Molecular function | vitamin D response element binding |
GO_0031435 | Molecular function | mitogen-activated protein kinase kinase kinase binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0070888 | Molecular function | E-box binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TCF3 |
Protein name | Transcription factor 3 Transcription factor E2-alpha (Transcription factor 3) Transcription factor E2-alpha (Class B basic helix-loop-helix protein 21) (bHLHb21) (Immunoglobulin enhancer-binding factor E12/E47) (Immunoglobulin transcription factor 1) (Kappa-E2-binding factor) (Transcription factor 3) (TCF-3) (Transcription factor ITF-1) Alternative protein TCF3 |
Synonyms | BHLHB21 E2A ITF1 |
Description | FUNCTION: Transcriptional regulator involved in the initiation of neuronal differentiation and mesenchymal to epithelial transition (By similarity). Heterodimers between TCF3 and tissue-specific basic helix-loop-helix (bHLH) proteins play major roles in determining tissue-specific cell fate during embryogenesis, like muscle or early B-cell differentiation (By similarity). Together with TCF15, required for the mesenchymal to epithelial transition (By similarity). Dimers bind DNA on E-box motifs: 5'-CANNTG-3' (By similarity). Binds to the kappa-E2 site in the kappa immunoglobulin gene enhancer . Binds to IEB1 and IEB2, which are short DNA sequences in the insulin gene transcription control region (By similarity). .; FUNCTION: [Isoform E47]: Facilitates ATOH7 binding to DNA at the consensus sequence 5'-CAGGTG-3', and positively regulates transcriptional activity. . |
Accessions | K7ENI0 ENST00000592628.5 ENST00000705032.1 ENST00000588136.7 [P15923-2] K7EPH6 A0A994J7B2 ENST00000587425.5 ENST00000586164.1 K7EK65 L0R8G9 ENST00000651991.1 ENST00000586318.1 ENST00000587235.6 K7ERZ7 A0A494C1R3 A0A0A0MTS0 K7EPS2 ENST00000453954.6 X6REB3 K7EJN4 ENST00000586410.2 K7ENH8 ENST00000593064.5 ENST00000585855.2 U5LXR9 Q6PJU3 ENST00000592395.5 ENST00000590684.5 P15923 ENST00000585731.5 ENST00000262965.12 [P15923-1] K7EMM4 K7ELF3 K7EKB9 ENST00000590436.5 ENST00000395423.7 [P15923-3] |